biosig_rgb.png
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
19 janv. 2023 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 19, 2023 (GLOBE NEWSWIRE) -- To date, the Company's FDA 510(k)-cleared PURE EP™ System has been used in approximately 3,000 patient cases across the United States The...
biosig_rgb.png
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
14 déc. 2022 16h30 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- - BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
14 déc. 2022 08h00 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
06 déc. 2022 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...
Bio-Sig-Logo-horiz.jpg
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
24 oct. 2022 11h03 HE | BioSig Technologies, Inc.
Westport, CT, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Medical Center of Excellence to leverage the Company’s PURE EP™ System to further its research and educational objectives as a leader in cardiac...
Bio-Sig-Logo-horiz.jpg
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
12 oct. 2022 10h00 HE | BioSig Technologies, Inc.
Westport, CT, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...
Bio-Sig-Logo-horiz.jpg
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base
07 oct. 2022 09h35 HE | BioSig Technologies, Inc.
Westport, CT, Oct. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented...
Bio-Sig-Logo-horiz.jpg
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
22 sept. 2022 09h00 HE | BioSig Technologies, Inc.
Westport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
30 août 2022 09h37 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Company increases sales efforts and strategy, adds new National Account Executives to accelerate commercial growth Strengthens marketing team with...
Bio-Sig-Logo-horiz.jpg
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
24 août 2022 09h17 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Leading Medical Center of Excellence adds second PURE EP™ System for evaluation, broadening physician access to the Company’s signal processing...